Search

Author/Creator Naing, A

1. 1127OA personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer. (23rd October 2018)

Authors:
Ott, P A; Govindan, R; Naing, A; Friedlander, T W; Margolin, K; Lin, J J; Bhardwaj, N; Hellman, M D; Srinivasan, L; Greshock, J; Moles, M; Gaynor, R B; Goldstein, M J; Hu-Lieskovan, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1130OResponses and durability of clinical benefit in renal cell carcinoma treated with pegilodecakin in combination with anti-PD-1 inhibitors. (23rd October 2018)

Authors:
Tannir, N M; Naing, A; Papadopoulos, K P; Wong, D J; Korn, W M; Aljumaily, R; Autio, K A; Pant, S; Bauer, T M; Drakaki, A; Daver, N; Hung, A; Oft, M; Leveque, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX). (23rd October 2018)

Authors:
Hecht, J R; Naing, A; Falchook, G S; Patel, M R; Aljumaily, R; Wong, D J; Autio, K A; Wainberg, Z A; Javle, M; Bendell, J; Pant, S; Hung, A; Oft, M; Leveque, J; Papadopoulos, K P
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1144PResponses and durability of clinical benefit in non-small cell lung cancer treated with pegilodecakin in combination with anti-PD-1 inhibitors. (23rd October 2018)

Authors:
Garon, E B; Wong, D J; Schneider, J G; Aljumaily, R; Korn, W M; Patel, M R; Autio, K A; Papadopoulos, K P; Naing, A; Gabrail, N; Munster, P N; Goldman, J; Hung, A; Oft, M; Leveque, J; Spigel, D R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. (23rd October 2018)

Authors:
Naing, A; Autio, K A; Falchook, G S; Meric-Bernstam, F; Litton, J K; Ibrahim, N K; Hung, A; Oft, M; Leveque, J; Patel, M R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 1154PA phase I study of MEDI1873, a novel GITR agonist, in advanced solid tumors. (23rd October 2018)

Authors:
Denlinger, C S; Infante, J R; Aljumaily, R; Naing, A; Chintakuntlawar, A; Rizvi, N A; Ross, H; Gordon, M; Kumar, R; Ma, M; Yan, L; Vicini, P; Standifer, N; Cann, J; Perera, A; Durham, N; Krishnan, S; Balmanoukian, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 435PPreliminary results of PROCLAIM-CX-072: The first-in-human, dose-finding trial of PD-L1 probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors. (23rd October 2018)

Authors:
Boni, V; Garcia-Corbacho, J; Ott, P A; Cho, D C; Autio, K A; Uboha, N; Spira, A I; Humphrey, R; Will, M; Naing, A; Thistlethwaite, F; de Vries, E G E; Arkenau, H-T
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts. (17th December 2018)

Authors:
Rischin, D; Gil-Martin, M; González-Martin, A; Brana, I; Hou, J Y; Cho, D; Falchook, G; Formenti, S; Jabbour, S; Moore, K; Naing, A; Papadopoulos, K P; Baranda, J; Weise, A; Fury, M G; Feng, M; Li, J; Lowy, I; Mathias, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗